Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: Is it useful?

Chinese Medical Journal

Volumn 123, Issue 13, 2010, Pages 1690-1694

  Liu, Zhao Yu ^a   Chang, Zhi hui ^a   Lu, Zai Ming ^a   Guo, Qi Yong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

18F FDG PET CT; Colorectal neoplasms; Fluorodeoxyglucose; Liver metastasis; Radiofrequency ablation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; LIVER METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; RADIATION RESPONSE; RADIOFREQUENCY ABLATION; TUMOR BIOPSY; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954528621     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.13.014     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. CA Cancer J Clin 2006; 56: 106-130.
2. Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984; 119: 647-651.
3. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 1990; 77: 1241-1246.
4. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases of the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996; 77: 1254-1262.
5. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-946.
6. Jarnagin WR, Fong Y, Ky A, Schwartz LH, Paty PB, Cohen AM, et al. Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease. J Am Coll Surg 1999; 188: 33-42.
7. Pereira PL. Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007; 17: 2062-2070.
8. Giovannini M, Moutardier V, Danisi C, Bories E, Pesenti C, Delpéro JR. Treatment of hepatocellula carcinoma using percutaneous radiofrequency thermoablation: result and outcomes in 56 patients. J Gastrointest Surg 2003; 7: 791-796.
9. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221: 159-166.
10. Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma:analysis of the pattern and risk factors. Eur J Radiol 2006; 59: 432-441.
11. Thanos L, Mylona S, Galani P, Pomoni M, Pomoni A, Koskinas I. Overcoming the heat-sink phenomenon: successful radoifrequency thermal ablation of liver tumors in contact with blood vessels. Diagn Interv Radiol 2008; 14: 51-56.
12. Kim SK, Lim HK, Kim YH, Lee WJ, Lee SJ, Kim SH, et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 2003; 23: 107-121.
13. Vogt FM, Antoch G, Veit P, Freudenberg LS, Blechschmid N, Diersch O, et al. Morphologic and functional changes in nonrumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, Ulstrasound and CT. J Nucl Med 2007; 48: 1836-1844.
14. Chopra S, Dodd GD 3rd, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. Am J Roentgenol 2001; 177: 381-387.
15. Coleman RE. PET in lung cancer. J Nucl Med 1999; 40: 814-820.
16. Antoch G, Vogt FM, Veit P, Freudenberg LS, Blechschmid N, Dirsch O, et al. Assessment of liver tissue after radiofrequency ablation:findings with different imaging procedures. J Nucl Med 2005; 46: 520-525.
17. Tsuda M, Rikimaru H, Majima K, Yamada T, Saito H, Ishibashi T, et al. Time-related changes of radiofrequency ablaton lession in the normal rabbit liver: findings of magnetic resonance imaging and histopathology. Invest Radiol 2003; 38: 525-531.
18. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 728-739.
19. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, PinsonCW. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 1998; 133: 510-515.
20. Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, et al. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 2002; 20: 4453-4458.
21. Erturk SM, Ichikawa T, Fujii H, Yasuda S, Ros PR. PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Radiol 2006; 58: 229-235.
22. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 2003; 28: 192-197.
23. Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Iida Y, Higuchi T, et al. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol Rep 2007; 18: 1469-1473.
24. Donckier V, Van Laethem JL, Goldman S, Van Gansbeke D, Feron P, Ickx B, et al. 18F fluorodeoxyglucose positron emission tomographyas a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 2003; 84: 215-223.
25. McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 1992; 3: 291-297.
26. Khandani AH, Calvo BF, O'Neil BH, Jorgenson J, Mauro MA. A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases. AJR 2007; 189: 1199-1202.
27. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver matastasis with dual-modality PET/CT: initial results. Eur Radiol 2006; 16: 80-87.